<p>Stratification analysis of the clinical measures in patients following regular therapy for SLE.</p
Objective. To determine if the BILAG-2004 index is sensitive to change for assessment of SLE disease...
<p>The linear regression curve and coefficient of determination yielded by the analysis of variance ...
<p>Stratified analysis of atherosclerosis measurements in subgroups of patients with their individua...
<p>Clinical characteristics of the patients with SLE included in the analyses.</p
<p>Multivariable analysis of the association between selected variables and plaques in 281 SLE patie...
<p>Demographic and disease manifestation in SLE patients and healthy controls.</p
<p>Univariate analysis of overall survival in NSCLC patients stratified based on clinical characteri...
Demographic features, clinical and laboratory manifestations and treatment of 120 SLE patients.</p
<p>Distribution of the American College of Rheumatology (ACR) 1982 classification criteria and patie...
<p>Note: SLEDAI: Systemic Lupus Erythematosus Disease Activity Index</p><p>Clinical and pathological...
<p>Assessment of clinical heterogeneity: subgroup analysis for order of treatment.</p
<p>Disease activity and chronic damage at baseline (T0) and after 10 years (T1) in 43 SLE patients.<...
<p>Demographics and Clinical characteristics of SLE patients used for the metabolomic profiling.</p
The alpha-diversity indices between SLE patients (red) and healthy controls (blue).</p
<p>Summary statistics of the data by treatment (SL and LS) and game (Skill and Luck).</p
Objective. To determine if the BILAG-2004 index is sensitive to change for assessment of SLE disease...
<p>The linear regression curve and coefficient of determination yielded by the analysis of variance ...
<p>Stratified analysis of atherosclerosis measurements in subgroups of patients with their individua...
<p>Clinical characteristics of the patients with SLE included in the analyses.</p
<p>Multivariable analysis of the association between selected variables and plaques in 281 SLE patie...
<p>Demographic and disease manifestation in SLE patients and healthy controls.</p
<p>Univariate analysis of overall survival in NSCLC patients stratified based on clinical characteri...
Demographic features, clinical and laboratory manifestations and treatment of 120 SLE patients.</p
<p>Distribution of the American College of Rheumatology (ACR) 1982 classification criteria and patie...
<p>Note: SLEDAI: Systemic Lupus Erythematosus Disease Activity Index</p><p>Clinical and pathological...
<p>Assessment of clinical heterogeneity: subgroup analysis for order of treatment.</p
<p>Disease activity and chronic damage at baseline (T0) and after 10 years (T1) in 43 SLE patients.<...
<p>Demographics and Clinical characteristics of SLE patients used for the metabolomic profiling.</p
The alpha-diversity indices between SLE patients (red) and healthy controls (blue).</p
<p>Summary statistics of the data by treatment (SL and LS) and game (Skill and Luck).</p
Objective. To determine if the BILAG-2004 index is sensitive to change for assessment of SLE disease...
<p>The linear regression curve and coefficient of determination yielded by the analysis of variance ...
<p>Stratified analysis of atherosclerosis measurements in subgroups of patients with their individua...
DOI
Add to ORKG